Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present framework, ...

A new report from the Lancet Global Commission calls for a shift in how obesity is diagnosed, moving beyond the traditional Body Mass Index (BMI). For years, Body Mass Index (BMI) has been the ...

With clinical obesity, the person may experience "severe end-organ damage, causing life-altering and potentially life-threatening complications," the researchers wrote. Potential effects of ...

The body mass index is not going away, a new report suggests, but it could be demoted to just a first step in making a more nuanced diagnosis of obesity as a disease, one that distinguishes ...

The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded. Using body-mass index (BMI) to tell who is overweight or obese is not reliable ...

Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...

On the other end, the commission members noted individuals with BMIs that define them as obese may not have excess fat, leading to an overdiagnosis of obesity.

By Gina Kolata Obesity should be assessed in a way that goes beyond the standard measure of body mass index, or B.M.I., according to a new definition of the condition released by an international ...

Just over a year after striking an obesity deal with Novo Nordisk, an SEC filing shows Flagship Pioneering spinout Omega ...

Even so, weight loss and other obesity-related improvements could contribute to overall lower cancer risks in the end. “If taking these drugs for a limited amount of time can help people lose ...